×
About 783 results

ALLMedicine™ Pleural Effusions Center

Research & Reviews  389 results

HΜGB1/sRAGE levels differ significantly between transudates and exudates.
https://doi.org/10.1016/j.cyto.2021.155469
Cytokine Kotsiou OS, Jagirdar RM et. al.

Feb 19th, 2021 - High mobility group box 1(HMGB1) protein operates as an alarmin with multiple roles in immunity and cell homeostasis. It is highly expressed in epithelial barrier sites and acts via the binding to the receptor for advanced glycation end products (...

Therapeutic thoracentesis symptoms and activity: a qualitative study.
https://doi.org/10.1136/bmjspcare-2020-002584
BMJ Supportive & Palliative Care; Twose C, Ferris R et. al.

Jan 9th, 2021 - Malignant pleural effusions (MPEs) commonly occur in patients with advanced cancer. Drainage of fluid is used to relieve symptoms and improve quality of life. To improve our understanding of how therapeutic aspiration affects symptoms and activiti...

Quality assessment of the guidelines for the management of malignant pleural effusions ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733286
World Journal of Surgical Oncology; Li JX, Shi YM et. al.

Dec 14th, 2020 - To fully assess the quality of the guidelines for the management of malignant pleural effusions (MPE) and ascites and reveal the heterogeneity of recommendations and possible reasons among guidelines. A systematic search was performed in the datab...

Characterization of soluble PD-L1 in pleural effusions of mesothelioma patients: potent...
https://doi.org/10.1007/s00432-020-03457-7 10.4049/jimmunol.1302044 10.21873/anticanres.13716 10.1007/s00262-006-0272-1 10.1007/s00418-017-1596-y 10.1056/NEJMoa1200694 10.1016/j.immuni.2007.05.016 10.1371/journal.pone.0121071e0121071 10.1016/j.humpath.2019.02.001 10.1016/j.cyto.2011.06.004 10.1038/s41586-018-0392-8 10.1186/s40425-019-0770-2 10.3390/cancers12020361 10.1038/nm730 10.3389/fonc.2018.00386 10.1016/j.ejca.2016.03.002 10.1158/1078-0432.CCR-10-0250 10.1038/s41598-020-62813-2 10.1084/jem.20180870 10.1073/pnas.0611533104 10.1038/nature14011 10.1016/j.humpath.2017.04.032 10.1073/pnas.192461099 10.1186/s12943-018-0928-4 10.1146/annurev.immunol.26.021607.090331 10.1016/j.jtho.2016.07.033 10.1080/2162402X.2017.1310358 10.1038/srep25952 10.1097/JTO.0000000000000177 10.3390/ijms19041041 10.1007/s12032-010-9515-2 10.1183/09031936.00000811 10.7554/eLife.50256 10.1158/1078-0432.CCR-06-2746 10.1158/1078-0432.CCR-04-1469 10.1016/j.lungcan.2016.11.023 10.1038/nrc3239 10.1016/j.jtho.2017.09.1968 10.1038/s41423-019-0245-x 10.1111/j.1600-6143.2012.04224.x 10.1007/s00262-016-1844-3 10.1056/NEJMoa1200690 10.1016/j.trsl.2009.12.001 10.3389/fimmu.2019.02022 10.3978/j.issn.1000-9604.2014.02.08 10.1158/2326-6066.CIR-16-0329 10.18632/oncotarget.18311 10.1038/nri2326
Journal of Cancer Research and Clinical Oncology; Carosio R, Fontana V et. al.

Nov 20th, 2020 - Programmed death-ligand 1 (PD-L1) protein plays a central role in the antitumor immune response, and appears to be a predictor of prognosis and efficacy for PD-L1 and programmed death 1 (PD-1) blockade therapy. The immunoregulatory role and progno...

Toxicity reduction and water expelling effect preservation of Shizaotang after its toxi...
https://doi.org/10.1016/j.jep.2020.113583
Journal of Ethnopharmacology; Zhang Q, Li ZL et. al.

Nov 15th, 2020 - Shizaotang (SZT), consisted of Euphorbia kansui S.L.Liou ex S.B.Ho (EK), Euphorbia pekinensis Rupr. (EP), Daphne genkwa Sieb. et Zucc. (DG,fried) and Ziziphus jujuba Mill. (ZJ), is usually used for treating malignant pleural effusions (MPE), but ...

see more →

Guidelines  1 results

ERS/EACTS statement on the management of malignant pleural effusions.
https://doi.org/10.1183/13993003.00349-2018
The European Respiratory Journal; Bibby AC, Dorn P et. al.

Jul 28th, 2018 - Malignant pleural effusions (MPE) are a common pathology, treated by respiratory physicians and thoracic surgeons alike. In recent years, several well-designed randomised clinical trials have been published that have changed the landscape of MPE m...

see more →

Clinicaltrials.gov  391 results

HΜGB1/sRAGE levels differ significantly between transudates and exudates.
https://doi.org/10.1016/j.cyto.2021.155469
Cytokine Kotsiou OS, Jagirdar RM et. al.

Feb 19th, 2021 - High mobility group box 1(HMGB1) protein operates as an alarmin with multiple roles in immunity and cell homeostasis. It is highly expressed in epithelial barrier sites and acts via the binding to the receptor for advanced glycation end products (...

Therapeutic thoracentesis symptoms and activity: a qualitative study.
https://doi.org/10.1136/bmjspcare-2020-002584
BMJ Supportive & Palliative Care; Twose C, Ferris R et. al.

Jan 9th, 2021 - Malignant pleural effusions (MPEs) commonly occur in patients with advanced cancer. Drainage of fluid is used to relieve symptoms and improve quality of life. To improve our understanding of how therapeutic aspiration affects symptoms and activiti...

Quality assessment of the guidelines for the management of malignant pleural effusions ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733286
World Journal of Surgical Oncology; Li JX, Shi YM et. al.

Dec 14th, 2020 - To fully assess the quality of the guidelines for the management of malignant pleural effusions (MPE) and ascites and reveal the heterogeneity of recommendations and possible reasons among guidelines. A systematic search was performed in the datab...

Characterization of soluble PD-L1 in pleural effusions of mesothelioma patients: potent...
https://doi.org/10.1007/s00432-020-03457-7 10.4049/jimmunol.1302044 10.21873/anticanres.13716 10.1007/s00262-006-0272-1 10.1007/s00418-017-1596-y 10.1056/NEJMoa1200694 10.1016/j.immuni.2007.05.016 10.1371/journal.pone.0121071e0121071 10.1016/j.humpath.2019.02.001 10.1016/j.cyto.2011.06.004 10.1038/s41586-018-0392-8 10.1186/s40425-019-0770-2 10.3390/cancers12020361 10.1038/nm730 10.3389/fonc.2018.00386 10.1016/j.ejca.2016.03.002 10.1158/1078-0432.CCR-10-0250 10.1038/s41598-020-62813-2 10.1084/jem.20180870 10.1073/pnas.0611533104 10.1038/nature14011 10.1016/j.humpath.2017.04.032 10.1073/pnas.192461099 10.1186/s12943-018-0928-4 10.1146/annurev.immunol.26.021607.090331 10.1016/j.jtho.2016.07.033 10.1080/2162402X.2017.1310358 10.1038/srep25952 10.1097/JTO.0000000000000177 10.3390/ijms19041041 10.1007/s12032-010-9515-2 10.1183/09031936.00000811 10.7554/eLife.50256 10.1158/1078-0432.CCR-06-2746 10.1158/1078-0432.CCR-04-1469 10.1016/j.lungcan.2016.11.023 10.1038/nrc3239 10.1016/j.jtho.2017.09.1968 10.1038/s41423-019-0245-x 10.1111/j.1600-6143.2012.04224.x 10.1007/s00262-016-1844-3 10.1056/NEJMoa1200690 10.1016/j.trsl.2009.12.001 10.3389/fimmu.2019.02022 10.3978/j.issn.1000-9604.2014.02.08 10.1158/2326-6066.CIR-16-0329 10.18632/oncotarget.18311 10.1038/nri2326
Journal of Cancer Research and Clinical Oncology; Carosio R, Fontana V et. al.

Nov 20th, 2020 - Programmed death-ligand 1 (PD-L1) protein plays a central role in the antitumor immune response, and appears to be a predictor of prognosis and efficacy for PD-L1 and programmed death 1 (PD-1) blockade therapy. The immunoregulatory role and progno...

Toxicity reduction and water expelling effect preservation of Shizaotang after its toxi...
https://doi.org/10.1016/j.jep.2020.113583
Journal of Ethnopharmacology; Zhang Q, Li ZL et. al.

Nov 15th, 2020 - Shizaotang (SZT), consisted of Euphorbia kansui S.L.Liou ex S.B.Ho (EK), Euphorbia pekinensis Rupr. (EP), Daphne genkwa Sieb. et Zucc. (DG,fried) and Ziziphus jujuba Mill. (ZJ), is usually used for treating malignant pleural effusions (MPE), but ...

see more →

News  2 results

Cardiovascular Medicine and Surgery NetWork
https://www.mdedge.com/chestphysician/article/214641/society-news/cardiovascular-medicine-and-surgery-network/page/0/1?channel=28399

Jan 17th, 2020 - Clinical pulmonary medicine Definitive pleural interventions in malignant pleural effusions Malignant pleural effusions (MPEs) contribute significantly to symptom burden, and an emphasis on patient-centered outcomes prioritizes palliation of sympt.

Test May Aid Mesothelioma Diagnosis
https://www.medpagetoday.com/pulmonology/lungcancer/15660

Aug 24th, 2009 - Action Points Explain to patients that measuring mesothelin, a glycoprotein released by mesothelioma cells into pleural fluid, may help improve physicians' ability to determine whether a patient has mesothelioma. Pleural-fluid mesothelin outperfor...

see more →